Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — the Mounjaro SmPC and patient information leaflet both recommend removing the pen from the fridge and allowing it to warm up before injecting. Injecting straight from refrigerator temperature (2–8°C) is not dangerous, but it can make the injection noticeably more uncomfortable. Room-temperature tirzepatide tends to sting less, flow more smoothly, and feel easier to hold during the injection. These are prescription-only medicines, and how you use them is covered in the leaflet that comes with your pen — always read it and follow your prescriber's guidance on technique.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC and patient information leaflet, published on the Electronic Medicines Compendium (eMC), set out the storage and preparation steps that Eli Lilly's clinical programme established as best practice. The pen is refrigerated between 2°C and 8°C. Before use, the leaflet advises allowing it to reach a more comfortable temperature. This guidance exists for a practical reason: viscous medicines flow through a small needle more easily at room temperature, and the skin and subcutaneous tissue respond less sharply to a warmer solution.
What the leaflet does not do is specify an exact number of minutes, because the rate at which a pen warms depends on ambient room temperature, the size of the pen, and whether you hold it in your hand or simply set it on a surface. A quick way to check readiness, used by many patients: hold the pen body loosely in your palm for 30 seconds and see whether the barrel feels close to body temperature. If it still feels obviously cold, give it a little longer. This is something you can do in under a minute before preparing your injection. For the precise window within which the pen remains usable outside the fridge, check the Mounjaro SmPC on the eMC, that figure matters and the leaflet carries the authoritative version.
If you want a deeper look at the permitted storage timeframes, how long Mounjaro can safely stay at room temperature is covered in detail on its own page, because the rules around extended out-of-fridge periods affect travel and everyday storage decisions differently from pre-injection warming.
Discomfort during or after a Mounjaro injection usually has more than one cause, and temperature is only part of the picture. The NHS patient information on tirzepatide notes that injection-site reactions (including pain, bruising, redness, or itching) are among the reported side effects. Rotating your site methodically helps: abdomen, thigh, and upper arm are all licensed sites, and returning to the same spot repeatedly can build up localised sensitivity.
Injection technique also plays a role. Pressing the pen firmly but without white-knuckle force, keeping the skin relaxed rather than taut, and injecting at a consistent angle all reduce friction and associated sting. Swabbing the site beforehand with a fresh alcohol swab and letting it dry fully before injecting is a small step that removes surface bacteria and avoids the sharp sensation that comes from injecting through wet skin.
For a full walkthrough of where and how to inject, our guide to Mounjaro injection technique covers the process step by step. If thigh injections are your preferred site, there are specific points about pinch angle and muscle proximity worth reading, our page on Mounjaro thigh injection location goes into that.
The warming question and the storage question are related but distinct. Brief removal from the fridge for pre-injection warming is part of normal use. Leaving the pen out of refrigeration for longer than the SmPC permits is a different matter, one that affects the medicine's stability and, ultimately, its effectiveness. The rules on how long a Mounjaro pen can be outside the fridge entirely are summarised in our guide on Mounjaro and room temperature storage, and that page also covers what to do if you have forgotten to refrigerate a pen overnight.
A few points worth noting regardless of how long the pen has been out. Never freeze a Mounjaro pen, if it has been frozen, even briefly, it should not be used. Keep it away from direct light and high heat during warming: a warm windowsill in summer is not the same thing as a cool kitchen counter. And if the solution inside looks cloudy, discoloured, or contains visible particles, do not inject it, contact our aftercare team or your prescriber.
People transferring to Mounjaro from another treatment, or those considering it for the first time, can find an overview of the medicine, its licence, and eligibility on our Mounjaro treatment page. If cost is a factor you are weighing, our Mounjaro price guide explains the market context honestly, including what a legitimate private prescription includes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.